Population-based epidemiology of invasive pneumococcal infection in children in nine urban centers in Canada, 1994 through 1998

被引:15
作者
Bjornson, GL [1 ]
Scheifele, DW
Halperin, SA
机构
[1] Univ British Columbia, Vaccine Evaluat Ctr, Vancouver, BC V5Z 1M9, Canada
[2] Dalhousie Univ, Clin Trials Res Ctr, Halifax, NS, Canada
[3] IMPACT, Ottawa, ON, Canada
关键词
Streptococcus pneumoniae; invasive infection; population-based incidence rates; children;
D O I
10.1097/00006454-200210000-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose. To describe the epidemiology of invasive pneumococcal infections in Canadian children 0 to 12 years old. Methods. At each of nine urban centers, active surveillance was conducted to identify all cases of invasive pneumococcal infection in children during 1994 to 1998. Postal codes were used to distinguish cases resident in defined urban areas from referral cases. Census data were obtained for each defined area to calculate age-specific incidence rates. Features of population-based cases were described. Results. From an average defined population of similar to1 million children, 937 eligible cases arose. Those 6 to 17 months old had the highest average incidence rate of 98.6/100000/year. The average cumulative risk of infection was 1 in 460 between birth and 59 months, by which age 92% of cases had occurred. Among cases younger than 2 years of age, simple bacteremia accounted for 66%, pneumonia with bacteremia accounted for 14.7% and meningitis accounted for 11% (average incidence rate, 9.0/100000/year). An underlying illness was present in 16% of all cases. The mortality rate was 1.8%. Conclusions. Invasive pneumococcal infections are relatively common in early childhood, based on 5 years of data from nearly 20% of the Canadian population ages 0 to 12 years. These data will be valuable for calculating the economic case for universal infant vaccination with newly available vaccines.
引用
收藏
页码:947 / 950
页数:4
相关论文
共 10 条
[1]   IMMUNIZATION OF UNITED-STATES CHILDREN WITH HEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE VACCINE - A COST-EFFECTIVENESS MODEL OF STRATEGY ASSESSMENT [J].
COCHI, SL ;
BROOME, CV ;
HIGHTOWER, AW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (04) :521-529
[2]   EPIDEMIOLOGY OF INVASIVE CHILDHOOD PNEUMOCOCCAL INFECTIONS IN ISRAEL [J].
DAGAN, R ;
ENGLEHARD, D ;
PICCARD, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (23) :3328-3332
[3]   EPIDEMIOLOGY OF INVASIVE PNEUMOCOCCAL INFECTIONS IN CHILDREN IN FINLAND [J].
ESKOLA, J ;
TAKALA, AK ;
KELA, E ;
PEKKANEN, E ;
KALLIOKOSKI, R ;
LEINONEN, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (23) :3323-3327
[4]   Six year multicenter surveillance of invasive pneumococcal infections in children [J].
Kaplan, SL ;
Mason, EO ;
Wald, ER ;
Tan, TQ ;
Schutze, GE ;
Bradley, JS ;
Givner, LB ;
Kim, KS ;
Yogev, R ;
Barson, WJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (02) :141-147
[5]   Invasive pneumococcal disease in Dallas County, Texas: Results from population-based surveillance in 1995 [J].
Pastor, P ;
Medley, F ;
Murphy, TV .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (03) :590-595
[6]   Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998 -: Opportunities for prevention in the conjugate vaccine era [J].
Robinson, KA ;
Baughman, W ;
Rothrock, G ;
Barrett, NL ;
Pass, M ;
Lexau, C ;
Damaske, B ;
Stefonek, K ;
Barnes, B ;
Patterson, J ;
Zell, ER ;
Schuchat, A ;
Whitney, CG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (13) :1729-1735
[7]   Invasive pneumococcal infections in Canadian children, 1991-1998: Implications for new vaccination strategies [J].
Scheifele, D ;
Halperin, S ;
Pelletier, L ;
Talbot, J .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) :58-64
[8]   Invasive pneumococcal disease in England and Wales: Vaccination implications [J].
Sleeman, K ;
Knox, K ;
George, R ;
Miller, E ;
Waight, P ;
Griffiths, D ;
Efstratiou, A ;
Broughton, K ;
Mayon-White, RT ;
Moxon, ER ;
Crook, DW .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (02) :239-246
[9]  
TAM T, 2002, CAN COMMUN DIS REP, V28, P1
[10]   Epidemiology of invasive pneumococcal disease in Southern California: Implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial [J].
Zangwill, KM ;
Vadheim, CM ;
Vannier, AM ;
Hemenway, LS ;
Greenberg, DP ;
Ward, JI .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04) :752-759